Adaptive Bayesian Randomization as a tool for Proof 
of Concept studies
Giacomo Mordenti - Senior Expert Biostatistician, Group Leader Global Biostatistics - Merck Serono S.A. Genève

• Challenges In Early Development Oncology trials

• Adaptive Randomization Process

• Simulation results from a Case -Study